DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Darifenacin

Darifenacin

  • Anticholinergic Drugs Improve Symptoms but Increase Dry Mouth in Adults with Overactive Bladder Syndrome

    Anticholinergic Drugs Improve Symptoms but Increase Dry Mouth in Adults with Overactive Bladder Syndrome

  • Solifenacin-Induced Delirium and Hallucinations☆

    Solifenacin-Induced Delirium and Hallucinations☆

  • 3 Drugs That May Cause Delirium Or Problem Behaviors CARD 03 19 12 JUSTIFIED.Pub

    3 Drugs That May Cause Delirium Or Problem Behaviors CARD 03 19 12 JUSTIFIED.Pub

  • Anticholinergic Drugs and Dementia

    Anticholinergic Drugs and Dementia

  • Anticholinergics for Overactive Bladder Evidence, Clinical Issues and Comparisons

    Anticholinergics for Overactive Bladder Evidence, Clinical Issues and Comparisons

  • Supplemental Table 1: Patient Characteristics, Interventions and Definitions/Variables of Persistence, Adherence and Discontinuation Reported in the Studies

    Supplemental Table 1: Patient Characteristics, Interventions and Definitions/Variables of Persistence, Adherence and Discontinuation Reported in the Studies

  • Comparision Effects of Solifenacin, Darifenacin, Propiverine on Ocular Parameters in Eyes: a Prospective Study ______

    Comparision Effects of Solifenacin, Darifenacin, Propiverine on Ocular Parameters in Eyes: a Prospective Study ______

  • Drug Benefit Council (DBC) Recommendation and Reasons for Recommendation FINAL

    Drug Benefit Council (DBC) Recommendation and Reasons for Recommendation FINAL

  • West Essex CCG Anticholinergic Side-Effects and Prescribing Guidance

    West Essex CCG Anticholinergic Side-Effects and Prescribing Guidance

  • Effects of YM905, a Novel Muscarinic M3-Receptor Antagonist, on Experimental Models of Bowel Dysfunction in Vivo

    Effects of YM905, a Novel Muscarinic M3-Receptor Antagonist, on Experimental Models of Bowel Dysfunction in Vivo

  • Tiotropium Bromide Inhibits TGF-Β-Induced MMP Production from Lung Fibroblasts by Interfering with Smad and MAPK Pathways in Vitro

    Tiotropium Bromide Inhibits TGF-Β-Induced MMP Production from Lung Fibroblasts by Interfering with Smad and MAPK Pathways in Vitro

  • Darifenacin: a Selective M3 Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder

    Darifenacin: a Selective M3 Muscarinic Receptor Antagonist for the Treatment of Overactive Bladder

  • Washington Preferred Drug List

    Washington Preferred Drug List

  • Therapeutic Class Overview Urinary Antispasmodics

    Therapeutic Class Overview Urinary Antispasmodics

  • Overactive Bladder

    Overactive Bladder

  • Drug-Induced Hyperhidrosis and Hypohidrosis Incidence, Prevention and Management

    Drug-Induced Hyperhidrosis and Hypohidrosis Incidence, Prevention and Management

  • Overactive Bladder Jack Barkin, MD Humber River Regional Hospital, University of Toronto, Toronto, Ontario, Canada

    Overactive Bladder Jack Barkin, MD Humber River Regional Hospital, University of Toronto, Toronto, Ontario, Canada

  • Maintenance Drug List

    Maintenance Drug List

Top View
  • Medicaid List of Covered Drugs (Formulary)
  • Biodrugs Potentially Harmful Medication Use and Decline In
  • Emselex, INN-Darifenacin
  • ENABLEX® (Darifenacin) Extended-Release Tablets Rx Only Prescribing Information
  • 3703-3712-Flavoxate in the Symptomatic Treatment of Overactive Bladder: a Meta-Analysis
  • An Oral Selective M3 Anticholinergic Receptor Antagonist in COPD Susan Lu, Pharmd
  • Oral Medicines for the Management of Urinary Incontinence, Frequency & Overactive Bladder
  • Use of Overactive Bladder Medications in the Adult Population Of
  • Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder Michael G
  • Bladder Relaxant Preparations
  • WHO Drug Information Vol 20, No
  • ANTICHOLINERGIC DRUGS.Pdf
  • Howcan Heat Illness Be Affected by Medications?
  • Outpatient Drug Formulary
  • Structure-Guided Development of Selective M3 Muscarinic Acetylcholine Receptor Antagonists
  • Drug Class Review on Agents for Overactive Bladder
  • 5-Tier Formulary
  • Recommendation from the New Drugs Committee


© 2024 Docslib.org    Feedback